Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
ImmunityBio Inc a leading immunotherapy company today announced the signing of a strategic Memorandum of Understanding MOU with the Ministry of Investment of Saudi Arabia MISA King Faisal Specialist Hospital Research Centre KFSHRC and King Abdullah...
Taiwanbased Formosa Pharmaceuticalsannounced that the company has entered into an exclusive licensing agreement with Adalvo Limited Adalvo in the European and Brazilian markets for exclusive rights
Waters Corporation today announced the launch of the BioResolve Protein A Affinity Columns with MaxPeak Premier Technology providing precise titer measurements This launch marks the first set of affinity chromatography
CARsgen Therapeutics Holdings Limited a company focused on developing innovative CAR Tcell therapies announces that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA
TCG Labs Soleil a venture firm integrating dedicated capital with an inhouse biotech RD hub and EpimAb Biotherapeutics Inc EpimAb today announced that Juri Biosciences Inc Juri a portfolio company of TCG Labs Soleil
Bristol Myers Squibb Canada BMS today announced that Health Canada has approved OPDIVO SC nivolumab for subcutaneous injection across all currently authorized solid tumour indications in monotherapy in the maintenance phase following combination
Eli Lilly and Company and SiteOne Therapeutics Inc a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders today announced a definitive agreement for Lilly t...
Drug Farm a private biotechnology company utilizing genetics and artificial intelligence technologies to discover and develop innovative immunemodulating therapies today announced that it has entered into an option agreement
RemeGen Co Ltd announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration NMPA for the treatment of adult patients with antiacetylcholine receptor AChR
Samsung Bioepis Co Ltd and Organon Co today announced that the US Food and Drug Administration FDA has designated the HADLIMA adalimumabbwwd high and lowconcentration mg mL mg mL autoinjectors
